Northern Trust’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.07M | Sell |
1,328,741
-102,925
| -7% | -$238K | ﹤0.01% | 2757 |
|
|
2025
Q1 | $1.99M | Sell |
1,431,666
-27,066
| -2% | -$37.6K | ﹤0.01% | 2927 |
|
|
2024
Q4 | $2.52M | Buy |
1,458,732
+86,207
| +6% | +$149K | ﹤0.01% | 2895 |
|
|
2024
Q3 | $2.76M | Buy |
1,372,525
+1,101,759
| +407% | +$2.21M | ﹤0.01% | 2798 |
|
|
2024
Q2 | $607K | Buy |
270,766
+59,371
| +28% | +$133K | ﹤0.01% | 3437 |
|
|
2024
Q1 | $607K | Sell |
211,395
-2,326
| -1% | -$6.68K | ﹤0.01% | 3499 |
|
|
2023
Q4 | $378K | Buy |
213,721
+147,531
| +223% | +$261K | ﹤0.01% | 3642 |
|
|
2023
Q3 | $209K | Sell |
66,190
-6,768
| -9% | -$21.4K | ﹤0.01% | 3800 |
|
|
2023
Q2 | $48.2K | Hold |
72,958
| – | – | ﹤0.01% | 4228 |
|
|
2023
Q1 | $58.2K | Hold |
72,958
| – | – | ﹤0.01% | 4226 |
|
|
2022
Q4 | $165K | Buy |
72,958
+33,031
| +83% | +$74.7K | ﹤0.01% | 3948 |
|
|
2022
Q3 | $77K | Buy |
39,927
+1,106
| +3% | +$2.13K | ﹤0.01% | 4204 |
|
|
2022
Q2 | $144K | Sell |
38,821
-166,804
| -81% | -$619K | ﹤0.01% | 4044 |
|
|
2022
Q1 | $1.34M | Sell |
205,625
-9,345
| -4% | -$60.9K | ﹤0.01% | 3286 |
|
|
2021
Q4 | $2.5M | Buy |
214,970
+3,042
| +1% | +$35.4K | ﹤0.01% | 3115 |
|
|
2021
Q3 | $3.95M | Buy |
211,928
+13,069
| +7% | +$243K | ﹤0.01% | 2880 |
|
|
2021
Q2 | $4.22M | Buy |
198,859
+101,935
| +105% | +$2.16M | ﹤0.01% | 2952 |
|
|
2021
Q1 | $1.97M | Sell |
96,924
-6,334
| -6% | -$129K | ﹤0.01% | 3251 |
|
|
2020
Q4 | $2.74M | Buy |
+103,258
| New | +$2.74M | ﹤0.01% | 3026 |
|